Fingolimod as a Potential Cerebroprotectant Results From the Stroke Preclinical Assessment Network

Although fingolimod did not significantly benefit the overall primary functional outcome, its effects varied with sex and comorbidity models, underscoring how the therapeutic potential of a particular drug can differ in a heterogeneous population.